Join us at the Annual Biologics Symposium to discuss the latest advances in the biologics field
The Annual Biologics Symposium is back for its eighth year, and we're confident that 2018 is going to be our most inspiring year yet!
This two day educational event brings together peers from across the biologics community to share information and discuss real life research, techniques and challenges in biological drug development.
We are delighted to have the following speakers confirmed for the symposium:
Dr. Richard Sainson - Director in Pharmacology and Translational Sciences, Kymab Ltd
KY1044, a novel anti-ICOS antibody, elicits long term in vivo anti-tumour efficacy as monotherapy or in combination with immune checkpoint inhibitors
Dr. Mark Aspinall-O'Dea - EMEA Business Development Manager, Retrogenix Ltd
Identifying critical target receptors and assessing specificity of biologics using cell microarray technology
Dr. Rocky Cranenburgh - Chief Scientific Officer, Prokarium Ltd
The Vaxonella platform for oral vaccine delivery using Salmonella
Dr. Katja Fiedler - Scientist, CureVac
Intratumoral RNA therapy for solid tumors
Dr. Tomáš Hanke - Professor in Vaccine Immunology, University of Oxford
HIV-1 Vaccines: Dealing with Diversity
Dr. Anne Goubier - VP Immunology, Tusk Therapeutics
Targeting CD38 beyond haematological malignancies: a panel of anti-CD38 antibodies with unique functional properties
Dr. Armin Sepp - Systems Modeling and Translational Biology, GSK
Predictive Physiologically-Based Pharmacokinetics (PBPK) for Biologics
Vasanthi Mowat - Director of Pathology, Envigo
Interpreting histopathology challenges with biologics: background, immune-mediated or pharmacology?
Dr. Jonathan Hare - Senior Manager, Vaccine Design & Development, IAVI
How understanding the host-pathogen relationship can contribute to rationale HIV CD-8 T-cell vaccine design (and beyond)
Dr. Fiona Sewell - Programme Manager in Toxicology and Regulatory Sciences, NC3Rs
Are we fully exploiting the use of a single species for post-‘First-in-Human’ (FIH) studies allowed within ICHS6?
Dr Keith Martin - CEO, Apitope
Apitopes® to treat the cause of autoimmune diseases: from concept to clinic
Dr. Neil Williams - Chief Scientific Officer/Founder, KWS BioTest
Daniel Rabbie - Regulatory Affairs Manager, Cell and Gene Therapy Catapult
The full agenda will be posted soon.
- Scientific insights you can apply right away.Delegates will hear from industry experts presenting insightful, informed and thought-provoking scientific content through a series of keynotes, best practice and case study sessions.
- Real questions answered by an industry expert.All presentations will be followed by a Q&A session ensuring delegates have the opportunity to have their real questions answered by an expert.
- Engage in thought-provoking discussions. Previous attendees have commented on the events non-commercial atmosphere and ability to achieve a perfect mix of big pharma, industry, academia and small biotech delegates. With this in mind, we've made sure the agenda allows for ample networking opportunities.
100% of delegates from our past three annual events have said they would attend again, so what are you waiting for? Register today to secure your seat!
We’re delighted to be hosting the 2018 event at the IET London: Savoy Place, which has recently undergone a £30 million refurbishment. Located on the River Thames, we’re confident that this inspiring venue will help make the eighth Annual Biologics Symposium one to remember. Click here to explore the venue.
Monday 1 October, 2018, 17:00 - 18:00 (straight after the closing remarks)
A chance to get together with fellow delegates and speakers to continue discussions and make new connections. Nibbles and drinks will be served in the Maxwell Library at the IET London: Savoy Place.
Questions, comments or suggestions?
Please get in touch, we'd love to hear from you. Our friendly events team can be reached via email: email@example.com via phone +44 (0)1480 892038.